These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26396551)

  • 1. Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.
    Mori S; Sugimoto M
    Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):29-40. PubMed ID: 26396551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.
    Mori S; Sugimoto M
    Rheumatology (Oxford); 2012 Dec; 51(12):2120-30. PubMed ID: 23001613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of
    Goto N; Takahashi-Nakazato A; Futamura K; Okada M; Yamamoto T; Tsujita M; Hiramitsu T; Narumi S; Tsuchiya K; Gatanaga H; Watarai Y; Oka S
    Transplant Direct; 2017 May; 3(5):e151. PubMed ID: 28573186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.
    Mori S; Cho I; Sugimoto M
    J Rheumatol; 2009 Aug; 36(8):1600-5. PubMed ID: 19531759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission.
    Vindrios W; Argy N; Le Gal S; Lescure FX; Massias L; Le MP; Wolff M; Yazdanpanah Y; Nevez G; Houze S; Dorent R; Lucet JC
    Clin Infect Dis; 2017 Oct; 65(7):1120-1126. PubMed ID: 28549105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control.
    Yiannakis EP; Boswell TC
    J Hosp Infect; 2016 May; 93(1):1-8. PubMed ID: 26996089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
    Braga BP; Prieto-González S; Hernández-Rodríguez J
    Med Clin (Barc); 2019 Jun; 152(12):502-507. PubMed ID: 30853123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole.
    Yukawa K; Nagamoto Y; Watanabe H; Funaki M; Iwahashi M; Yamana J; Sasaki R; Yamana S
    J Clin Rheumatol; 2018 Oct; 24(7):355-360. PubMed ID: 29664819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.
    Ohmura SI; Homma Y; Masui T; Miyamoto T
    Intern Med; 2022 Apr; 61(7):997-1006. PubMed ID: 34511571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by
    Shiba H; Kotani T; Nagai K; Hata K; Yamamoto W; Yoshikawa A; Wada Y; Hiramatsu Y; Makino H; Ueda Y; Onishi A; Murata K; Amuro H; Son Y; Hara R; Hirano T; Ebina K; Katayama M; Hashimoto M; Takeuchi T
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of outbreaks of Pneumocystis jirovecii pneumonia in two Scottish renal units.
    Inkster T; Dodd S; Gunson R; Imrie L; Spalding E; Packer S; Deighan C; Daly C; Coia J; Imtiaz T; McGuffie C; Wilson R; Bal AM
    J Hosp Infect; 2017 Jun; 96(2):151-156. PubMed ID: 28169011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.
    Mori S; Cho I; Ichiyasu H; Sugimoto M
    Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
    Nunokawa T; Chinen N; Shimada K; Kimura M; Tateishi M; Chen FY; Setoguchi K; Sugihara M
    J Infect Chemother; 2023 Feb; 29(2):193-197. PubMed ID: 36334836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Pneumocystis Pneumonia Developed During Rheumatoid Arthritis Treatment With Methotrexate and Golimumab.
    Yanagihara T; Oka Y; Moriwaki A; Moriuchi Y; Ogata H; Ishimatsu A; Otsuka J; Taguchi K; Yoshida M
    Cureus; 2024 Jan; 16(1):e52944. PubMed ID: 38406039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
    Özkoç S; Bayram Delibaş S
    Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.